Nevro's HFX iQ spinal cord stimulator earned the European Union's CE mark, the company said Nov. 12. HFX iQ has already earned FDA approval in 2022, according to a news release. The spinal cord ...

A key highlight of the quarter came right at the end when Nevro won FDA approval for HFX AdaptiveAI, an AI-powered, ...

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the ...

Chris Patterson retired before Christmas 2022, after falling and breaking his back. He has faced several issues trying to get ...

Inceptiv is a small device, implanted in the lower torso with leads to the spinal cord, that provides responsive counter-stimulation to relieve chronic pain. The device was approved by the FDA in ...

Since the passing of Professor Emeritus Alan Mackay-Sim AM in 2023, his ground-breaking legacy research is about to be realized with a Phase I human clinical trial commencing to test the efficacy and ...

Australian researchers are about to launch a human trial to treat spinal cord injury by transplanting cells from the noses of paralysed patients into the damaged area. Griffith University ...

The company announced receiving CE Mark Certification in Europe for its HFX iQ spinal cord stimulation system ... The Senza ...